Table 1 Patients’ characteristics per chronic lung disease.

From: Telemonitoring of daily activities compared to the six-minute walk test further completes the puzzle of oximetry-guided interventions

 

Total

COPD

ILD

Asthma

Bronch

Other

N = 100

N = 41

N = 22

N = 15

N = 10

N = 12

Male, n (%)

50 (50.0)

31 (75.6)

8 (36.4)

4 (26.7)

3 (30.0)

4 (33.3)

Age (years; mean ± SD)

66.1 ± 9.8

68.0 ± 7.2

63.5 ± 9.5

66.0 ± 11.9

68.0 ± 13.2

63.2 ± 11.9

Anthropometry

Weight (Kg; mean ± SD)

69.7 ± 15.0

71.4 ± 14.5

70.0 ± 15.9

72.0 ± 14.3

63.4 ± 12.7

65.5 ± 17.8

Height (m; mean ± SD)

1.62 ± 0.1

1.66 ± 0.1

1.59 ± 0.1

1.56 ± 0.1

1.60 ± 0.1

1.62 ± 0.1

BMI (Kg/m2; mean ± SD)

26.5 ± 5.1

25.8 ± 5.0

27.7 ± 5.6

29.4 ± 5.0

24.5 ± 4.0

24.7 ± 4.2

Pulmonary function

FEV1 pred (%; mean ± SD)

62.1 ± 27.2

53.2 ± 25.8

71.3 ± 20.0

78.6 ± 31.0

69.6 ± 35.7

63.3 ± 23.4

FVC pred (%; mean ± SD)

80.2 ± 25.5

86.5 ± 25.0

69.7 ± 18.0

94.1 ± 26.3

84.4 ± 23.0

84.5 ± 13.8

FEV1/FVC (%; mean ± SD)

73.3 ± 25.1

57.3 ± 20.3

101.4 ± 19.6

77.5 ± 19.1

70.8 ± 19.2

69.8 ± 24.1

TLC pred (%; mean ± SD)

102.5 ± 27.6

117.3 ± 21.7

73.0 ± 22.4

108.3 ± 22.8

110.3 ± 14.8

107.2 ± 26.6

RV pred (%; mean ± SD)

142.1 ± 63.9

173.4 ± 65.2

82.8 ± 58.2

134.8 ± 36.0

158.7 ± 31.0

147.2 ± 63.1

DLCO pred (%; mean ± SD)

57.0 ± 24.4

52.1 ± 23.9

47.2 ± 18.5

80.0 ± 13.6

65.3 ± 35.8

61.1 ± 12.7

Smoking status

Non-smoker, n (%)

40 (40.0)

2 (4.9)

11 (50.0)

9 (60.0)

10 (100)

8 (66.7)

Former smoker, n (%)

52 (52.0)

34 (82.9)

10 (45.5)

4 (26.7)

0 (0.0)

4 (33.3)

Active smoker, n (%)

8 (8.0)

5 (12.2)

1 (4.5)

2 (13.3)

0 (0.0)

0 (0.0)

LTOT, n (%)

29 (29.0)

16 (39.0)

11 (50.0)

0 (0.0)

1 (10.0)

1 (8.3)

Nocturnal NIV, n (%)

12 (12.0)

5 (12.2)

3 (13.6)

3 (20.0)

1 (10.0)

0 (0.0)

  1. COPD: chronic obstructive pulmonary disease; ILD: interstitial lung disease; Bronch.: bronchiectasis; Other: post-thoracic surgery, lung cancer, tuberculosis sequelae, lung disorder associated with connective tissue disease and pulmonary ossification; SD: standard deviation; BMI: body mass index; FEV1 pred: predicted forced expiratory volume in 1 s; FVC pred: predicted forced vital capacity; FEV1/FVC: forced expiratory volume in 1 s and forced vital capacity ratio; TLC pred: predicted total lung capacity; RV pred: predicted residual volume; DLCO pred: predicted diffusion capacity of the lungs for carbon monoxide; LTOT: long-term oxygen therapy; NIV: non-invasive ventilation.
Back to article page